R1

Same country, different risks: why Iranian women’s heart disease profiles expose a blind spot in prevention policy

KRAS Has a New Contender. It Still Has to Earn Its Place.

Indigenous cardiovascular inequity is not a data gap. It is a policy failure

China’s Biliary-Cancer Bet Has a Global Access Problem

NTDs Are Now A Human-Rights Issue. Budgets Must Follow.

A CE Mark Is Not Access

ALS Needs Proof, Not Just Another Biomarker

MENA’s cardiometabolic crisis is a stability issue

Mpox Reached Guinea-Bissau. Stigma Must Not Win.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
